Company / EPS (Diluted)
Forte Biosciences, Inc. EPS (Diluted) History
FY2018-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$2.66
FY2019
5-year range
-$15.22 / -$2.66
FY2018-FY2019
Trend
+82.5%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-2.66 in FY2019.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, eps (diluted) increased 82.5% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.72 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2019 | -$2.66 | +82.5% |
| FY2018 | -$15.22 | - |
As of FY2019 · SEC 10-K Annual Filings · Updated Jun 24, 2026